Family Medicine · Garden Grove, CA
NPI
1457445124
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
12828 Harbor Blvd, Suite 230
Garden Grove, CA, 92840
Phone (714) 741-4900
Groups this clinician bills Medicare through
Medicare paid, 2024
$781K
14,607 services
Medicare patients, 2024
290
Average age 82
Drug cost, 2024
$5.6M
18,405 prescriptions
Company payments, 2025
$2,160
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eddie C Pyune was code J1010 (injection, methylprednisolone acetate, 1 mg), 1,900 times for 44 patients. In total Eddie C Pyune billed 14,607 services in 85 codes, and Medicare paid $781K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-01-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,900 | 44 | $0.10 | $194 |
| 99213 Office E&M - Established | Office | 1,695 | 256 | $80.38 | $136K |
| 99214 Office E&M - Established | Office | 1,497 | 277 | $111.40 | $167K |
| 99457 E&M - Miscellaneous | Office | 1,282 | 163 | $46.17 | $59K |
| 99454 E&M - Miscellaneous | Office | 1,180 | 145 | $47.42 | $56K |
| 36415 Venipuncture Blood Collection | Office | 946 | 273 | $8.65 | $8,179 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 710 | 102 | $44.85 | $32K |
| 99458 E&M - Miscellaneous | Office | 638 | 95 | $36.61 | $23K |
| 99442 Telephone Services | Office | 624 | 235 | $83.36 | $52K |
| 96372 Injection Administration | Office | 610 | 199 | $12.37 | $7,543 |
| 99441 Telephone Services | Office | 417 | 201 | $52.31 | $22K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 404 | 102 | $58.13 | $23K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 366 | 246 | $180.37 | $66K |
| 99212 Office E&M - Established | Office | 343 | 158 | $51.58 | $18K |
| 93306 Echocardiography (TTE/TEE) | Office | 300 | 219 | $176.52 | $53K |
By year: 2022 $686K for 12,316 services; 2023 $598K for 11,110 services; 2024 $781K for 14,607 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 946 | 273 | $8.65 | $8,179 |
| 81003 Clinical Chemistry | 85 | 56 | $2.20 | $187 |
| 82962 Clinical Chemistry | 73 | 38 | $3.21 | $234 |
| 83036 Blood Count | 70 | 38 | $9.52 | $666 |
Medicare prescription drug claims, 2024
In 2024, the drug Eddie C Pyune prescribed most often to Medicare patients was Rosuvastatin Calcium, with 1,022 prescriptions and refills. In total Eddie C Pyune wrote 18,405 Medicare prescriptions that cost $5.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 1,022 | 1,629 | 155 | $7,401 |
| Repatha Sureclick Evolocumab | 838 | 1,037 | 134 | $586K |
| Vascepa Icosapent Ethyl | 664 | 897 | 132 | $306K |
| Repatha Pushtronex Evolocumab | 664 | 875 | 119 | $514K |
| Dexlansoprazole Dr Dexlansoprazole | 567 | 754 | 85 | $144K |
| Olmesartan Medoxomil Generic | 529 | 759 | 72 | $2,976 |
| Creon Lipase/Protease/Amylase | 512 | 661 | 105 | $676K |
| Amlodipine Besylate Generic | 480 | 685 | 64 | $733 |
| Lidocaine Generic | 413 | 516 | 73 | $99K |
| Levothyroxine Sodium Generic | 407 | 596 | 52 | $1,684 |
| Ztlido Lidocaine | 347 | 406 | 59 | $283K |
| Jardiance Empagliflozin | 341 | 454 | 46 | $271K |
| Metoprolol Succinate Generic | 339 | 449 | 46 | $1,703 |
| Prolia Denosumab | 311 | 1,866 | 164 | $524K |
| Icosapent Ethyl Generic | 292 | 329 | 89 | $39K |
Brand drugs: 7,020 claims; generic drugs: 11,146 claims; opioid claims: 101.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Eddie C Pyune $2,160 ($2,160 in general payments such as food, travel and fees) from 14 companies. The largest payer was Amgen Inc. with $425.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 30 | $425 |
| Aimmune Therapeutics, Inc. | 16 | $376 |
| AstraZeneca Pharmaceuticals LP AZN | 12 | $280 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $252 |
| Ardelyx, Inc. ARDX | 12 | $245 |
| Abbvie Inc. ABBV | 18 | $220 |
| Lilly USA, LLC LLY | 5 | $104 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $64.74 |
| GlaxoSmithKline, LLC. GSK | 2 | $46.57 |
| Sumitomo Pharma America, Inc. 4506.T | 2 | $46.3 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.